Voydeya approved in EU as add-on treatment to ravulizumab

eAwazMedicine

London – Voydeya (danicopan) has been approved in the European Union (EU) as an add-on to ravulizumab or eculizumab for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have residual haemolytic anaemia.1 Voydeya is a first-in-class, oral, Factor D inhibitor developed as an add-on to standard-of-care Ultomiris (ravulizumab) or Soliris (eculizumab) to address the needs of the approximately 10-20% of patients with PNH who experience clinically significant …

Imfinzi plus chemotherapy doubled overall survival rate

eAwazMedicine

London – Updated exploratory results from the TOPAZ-1 Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with standard-of-care chemotherapy demonstrated a clinically meaningful long-term overall survival (OS) benefit at three years for patients with advanced biliary tract cancer (BTC). These results from TOPAZ-1, which are the longest survival follow-up ever reported for a global, randomised Phase III trial in this …

Catch up on vaccines during National Immunization Awareness Week

eAwazMedicine

Toronto – Mayor Olivia Chow officially proclaimed National Immunization Awareness Week in Toronto. This week, Toronto Public Health (TPH) is encouraging residents to catch up on all routine and other lifesaving immunizations for which they are eligible. National Immunization Awareness Week – which coincides with the World Health Organization’s (WHO) World Immunization Week – highlights the importance of staying up …

New modelling reveals escalating toll of chronic kidney disease 

eAwazMedicine

London – A new modelling analysis by AstraZeneca, IMPACT CKD, forecasts up to 16.5% of the population across eight countries will suffer from chronic kidney disease (CKD) by 2032, including a rise of up to 59.3% in advanced-stage.1 Presented at the 2024 ISN World Congress of Nephrology (WCN’24) in Buenos Aires, the study highlights an urgent and growing global health crisis …

Improving Care for People with Eating Disorders

eAwazMedicine

Ottawa – Prior to the COVID-19 pandemic, eating disorders were common, with a lifetime prevalence of about 15% (the proportion of the population who will experience an eating disorder at some point in their life). But, as with other mental health conditions – including depression and anxiety – the incidence of eating disorders appears to have increased through the pandemic. …

Getting Health Care in Ontario

eAwazMedicine

Ontario – Find information about new health care services Health Ontario manages, and the health care services previously managed by the agencies that now make up Ontario Health. You can also get connected to health care services 24/7 through Health811. Use the health services directory tool to search by type of service or location. One of the framework’s key areas of …

Flu-like symptoms and gastroenteritis

eAwazMedicine

Quebec – Most people infected with an infectious respiratory disease recover in about 2 weeks without special medical attention. So, in most cases, you can practise self-care at home. Managing symptoms in adults Rest: You probably feel weak and tired. While rest will help you fight the disease, it’s not good to stay in bed all the time. Resume your normal …

Immunization for babies, children and teens

eAwazMedicine

Alberta – By following Alberta’s routine immunization schedule, your child will be immunized against diseases at the most effective ages and stages, giving them the maximum possible protection. Public health nurses give vaccines according to Alberta’s routine immunization schedule. This schedule is based on scientific research. It helps you to know when your child should get their vaccines in a timely …

Prostate cancer cases increasing, what`s the cure?

eAwazMedicine

London  – A new study warns that prostate cancer cases will increase substantially worldwide over the next two decades. This rise is linked to a growing population of elderly people. The study warns that the number of cases could double by 2040. The number could reach nearly 3 million annually by 2040, compared to 1.4 million in 2020. In high-income …

New medicine to treat pancreatic cancers

eAwazMedicine

Washington – A new medicine has been approved by the US Foods and Drug administration (FDA) that can treat types of pancreatic cancer, per Fox News. Onivyde (irinotecan liposome) is the first medicine in nearly a decade that can treat the aggressive illness The patients were injected with the new regimen which includes Onivyde, oxaliplatin, fluorouracil and leucovorin. According to …